Literature DB >> 17389008

Thalidomide causes platelet activation, which can be abrogated by aspirin.

S Dunkley, L Gaudry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389008     DOI: 10.1111/j.1538-7836.2007.02542.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  6 in total

1.  Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.

Authors:  Sigurdur Y Kristinsson; Ruth M Pfeiffer; Magnus Björkholm; Lynn R Goldin; Sam Schulman; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2010-03-18       Impact factor: 22.113

2.  Thromboprophylaxis in multiple myeloma: is the evidence there?

Authors:  Sigurdur Yngvi Kristinsson; Ola Landgren
Journal:  Expert Rev Anticancer Ther       Date:  2012-03       Impact factor: 4.512

Review 3.  Drug-induced thrombosis: an update.

Authors:  Yuval Ramot; Abraham Nyska; Galia Spectre
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

4.  Hemostatic changes after 1 month of thalidomide and dexamethasone therapy in patients with multiple myeloma.

Authors:  Marta Robak; Jacek Treliński; Krzysztof Chojnowski
Journal:  Med Oncol       Date:  2012-07-07       Impact factor: 3.064

5.  An absence of platelet activation following thalidomide treatment in vitro or in vivo.

Authors:  Jianlin Qiao; Yulu Wu; Xiaoqing Wu; Yun Liu; Xiaoqian Li; Wen Ju; Kunming Qi; Depeng Li; Elizabeth E Gardiner; Robert K Andrews; Lingyu Zeng; Kailin Xu
Journal:  Oncotarget       Date:  2017-05-30

Review 6.  Cancer Therapy-Associated Thrombosis.

Authors:  Steven P Grover; Yohei M Hisada; Raj S Kasthuri; Brandi N Reeves; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-02-11       Impact factor: 8.311

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.